New Key Statistics Module, Z-Score and F-Score
HKSE:02269 Key Ratios
Market Cap HK$ M | 58,110.82 |
Enterprise Value HK$ M | 48,891.57 |
P/E(ttm) | 16.58 |
PE Ratio without NRI | 14.13 |
Forward PE Ratio | 12.46 |
Price/Book | 1.35 |
Price/Sales | 3.27 |
Price/Free Cash Flow | 50.04 |
Price/Owner Earnings | 64.65 |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 18,631.00 |
EPS (TTM) HK$ | 0.84 |
Beneish M-Score | -2.38 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 63.90 |
y-y EBITDA Growth Rate % | -3.00 |
EV-to-EBIT | 10.32 |
EV-to-EBITDA | 10.32 |
PEG | 0.22 |
Shares Outstanding M | 4,162.67 |
Net Margin (%) | 19.96 |
Operating Margin % | 26.13 |
Pre-tax Margin (%) | 24.50 |
Quick Ratio | 2.54 |
Current Ratio | 2.78 |
ROA % (ttm) | 6.40 |
ROE % (ttm) | 8.96 |
ROIC % (ttm) | 9.42 |
Dividend Yield % | -- |
Altman Z-Score | 3.15 |
HKSE:02269 Number of Guru Trades
HKSE:02269 Volume of Guru Trades
Gurus Latest Trades with HKSE:02269
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02269 is held by these investors
Total 1
WuXi Biologics (Cayman) Inc Insider Transactions
No Available Data